DeepUll announced on Tuesday that it has entered into a €20 million ($21.3 million) loan agreement with the European Investment Bank.

The venture loan will be used to finance research, development, and investigation activities for DeepUll’s culture-free diagnostics platform for the early identification of sepsis and other acute infections. The funding will allow the company to further develop its automated device, DeepUll said in a statement.

Read the full news here